# DILTIAZEM HYDROCHLORIDE
> **ANDA218032** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2025-07-02
## Drug
- **FDA Application Number:** ANDA218032
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DILTIAZEM HYDROCHLORIDE
- **Generic name:** DILTIAZEM HYDROCHLORIDE
- **Active ingredients:** DILTIAZEM HYDROCHLORIDE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **Manufacturer:** Ingenus Pharmaceuticals, LLC
- **First approval:** 2025-07-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218032)
---
*AI Analytics · CC0 1.0*